Current Gene Therapy

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard


Most Accessed Articles

Tet-On Systems For Doxycycline-inducible Gene Expression open access plus

Volume: 16   Issue: 3
Pp: 156-167
Atze T. Das, Liliane Tenenbaum and Ben Berkhout
DOI: 10.2174/1566523216666160524144041

Order Reprints Order Eprints

Prospects and Limitations of T Cell Receptor Gene Therapy

Volume: 11   Issue: 4
Pp: 276-287
Annelies Jorritsma, Remko Schotte, Miriam Coccoris, Moniek A. de Witte and Ton N.M. Schumacher
DOI: 10.2174/156652311796150390

Order Reprints Order Eprints

Immune Responses to AAV in Clinical Trials open access plus

Volume: 11   Issue: 4
Pp: 321-330
Federico Mingozzi and Katherine A. High
DOI: 10.2174/156652311796150354

Order Reprints Order Eprints

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair

Volume: 17   Issue: 1
Pp: 29-42
Arash Aghajani Nargesi, Lilach O. Lerman and Alfonso Eirin
DOI: 10.2174/1566523217666170412110724

Order Reprints Order Eprints

Phage-Mediated Gene Therapy

Volume: 17   Issue: 2
Pp: 120-126
Zeinab Hosseinidoust
DOI: 10.2174/1566523217666170510151940

Order Reprints Order Eprints

Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus

Volume: 16   Issue: 6
Pp: 419-428
Ferdaous Allagui, Carole Achard, Clarisse Panterne, Chantal Combredet, Nathalie Labarrière, Brigitte Dréno, Amel Benammar Elgaaied, Daniel Pouliquen, Frédéric Tangy, Jean-François Fonteneau, Marc Grégoire and Nicolas Boisgerault
DOI: 10.2174/1566523217666170102110502

Order Reprints Order Eprints